Literature DB >> 16007187

Gene expression analysis reveals a strong signature of an interferon-induced pathway in childhood lymphoblastic leukemia as well as in breast and ovarian cancer.

Uri Einav1, Yuval Tabach, Gad Getz, Assif Yitzhaky, Ugur Ozbek, Ninette Amariglio, Shai Izraeli, Gideon Rechavi, Eytan Domany.   

Abstract

On the basis of epidemiological studies, infection was suggested to play a role in the etiology of human cancer. While for some cancers such a role was indeed demonstrated, there is no direct biological support for the role of viral pathogens in the pathogenesis of childhood leukemia. Using a novel bioinformatic tool that alternates between clustering and standard statistical methods of analysis, we performed a 'double-blind' search of published gene expression data of subjects with different childhood acute lymphoblastic leukemia (ALL) subtypes, looking for unanticipated partitions of patients, induced by unexpected groups of genes with correlated expression. We discovered a group of about 30 genes, related to the interferon response pathway, whose expression levels divide the ALL samples into two subgroups; high in 50, low in 285 patients. Leukemic subclasses prevalent in early childhood (the age most susceptible to infection) are over-represented in the high-expression subgroup. Similar partitions, induced by the same genes, were found also in breast and ovarian cancer but not in lung cancer, prostate cancer and lymphoma. About 40% of breast cancer samples expressed the 'interferon-related' signature. It is of interest that several studies demonstrated mouse mammary tumor virus-like sequences in about 40% of breast cancer samples. Our discovery of an unanticipated strong signature of an interferon-induced pathway provides molecular support for a role for either inflammation or viral infection in the pathogenesis of childhood leukemia as well as breast and ovarian cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16007187     DOI: 10.1038/sj.onc.1208797

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  32 in total

1.  Functional connectivity mapping using the ferromagnetic Potts spin model.

Authors:  Larissa Stanberry; Alejandro Murua; Dietmar Cordes
Journal:  Hum Brain Mapp       Date:  2008-04       Impact factor: 5.038

2.  An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers.

Authors:  Steven A Roberts; Michael S Lawrence; Leszek J Klimczak; Sara A Grimm; David Fargo; Petar Stojanov; Adam Kiezun; Gregory V Kryukov; Scott L Carter; Gordon Saksena; Shawn Harris; Ruchir R Shah; Michael A Resnick; Gad Getz; Dmitry A Gordenin
Journal:  Nat Genet       Date:  2013-07-14       Impact factor: 38.330

3.  Subtype-dependent prognostic relevance of an interferon-induced pathway metagene in node-negative breast cancer.

Authors:  Maurizio Callari; Valeria Musella; Eleonora Di Buduo; Marialuisa Sensi; Patrizia Miodini; Matteo Dugo; Rosaria Orlandi; Roberto Agresti; Biagio Paolini; Maria Luisa Carcangiu; Vera Cappelletti; Maria Grazia Daidone
Journal:  Mol Oncol       Date:  2014-05-04       Impact factor: 6.603

4.  An interferon response gene expression signature is activated in a subset of medulloblastomas.

Authors:  Eike Staub
Journal:  Transl Oncol       Date:  2012-08-01       Impact factor: 4.243

Review 5.  Interactions among genes, tumor biology and the environment in cancer health disparities: examining the evidence on a national and global scale.

Authors:  Tiffany A Wallace; Damali N Martin; Stefan Ambs
Journal:  Carcinogenesis       Date:  2011-04-03       Impact factor: 4.944

6.  Up-regulation of NG2 proteoglycan and interferon-induced transmembrane proteins 1 and 3 in mouse astrocytoma: a membrane proteomics approach.

Authors:  Nicholas T Seyfried; Leanne C Huysentruyt; James A Atwood; Qiangwei Xia; Thomas N Seyfried; Ron Orlando
Journal:  Cancer Lett       Date:  2008-02-20       Impact factor: 8.679

7.  The TEL-AML1 leukemia fusion gene dysregulates the TGF-beta pathway in early B lineage progenitor cells.

Authors:  Anthony M Ford; Chiara Palmi; Clara Bueno; Dengli Hong; Penny Cardus; Deborah Knight; Giovanni Cazzaniga; Tariq Enver; Mel Greaves
Journal:  J Clin Invest       Date:  2009-03-16       Impact factor: 14.808

Review 8.  Breast cancer and the immune system.

Authors:  Leanna J Standish; Erin S Sweet; Jeffrey Novack; Cynthia A Wenner; Carly Bridge; Ana Nelson; Mark Martzen; Carolyn Torkelson
Journal:  J Soc Integr Oncol       Date:  2008

Review 9.  Biological determinants of health disparities in prostate cancer.

Authors:  Damali N Martin; Adrienne M Starks; Stefan Ambs
Journal:  Curr Opin Oncol       Date:  2013-05       Impact factor: 3.645

10.  STAT1 and NF-κB Inhibitors Diminish Basal Interferon-Stimulated Gene Expression and Improve the Productive Infection of Oncolytic HSV in MPNST Cells.

Authors:  Joshua D Jackson; James M Markert; Li Li; Steven L Carroll; Kevin A Cassady
Journal:  Mol Cancer Res       Date:  2016-02-16       Impact factor: 5.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.